MINAPHARM Pharmaceuticals

CASE:MIPH Stock Report

Market Cap: ج.م7.8b

MINAPHARM Pharmaceuticals Past Earnings Performance

Past criteria checks 1/6

MINAPHARM Pharmaceuticals's earnings have been declining at an average annual rate of -32%, while the Pharmaceuticals industry saw earnings growing at 22.2% annually. Revenues have been growing at an average rate of 20.6% per year. MINAPHARM Pharmaceuticals's return on equity is 0.7%, and it has net margins of 0.6%.

Key information

-31.97%

Earnings growth rate

-30.85%

EPS growth rate

Pharmaceuticals Industry Growth9.80%
Revenue growth rate20.63%
Return on equity0.74%
Net Margin0.62%
Last Earnings Update31 Dec 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How MINAPHARM Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

CASE:MIPH Revenue, expenses and earnings (EGP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 256,438401,045225
30 Sep 256,9241121,113192
30 Jun 256,9362211,095168
31 Mar 256,288166986142
31 Dec 245,665128872131
30 Sep 244,423-127737149
30 Jun 243,916-259701156
31 Mar 243,904-154740154
31 Dec 233,892-55726151
30 Sep 234,025281653127
30 Jun 234,00346160398
31 Mar 233,79452952576
31 Dec 223,62159047259
30 Sep 223,44254445646
30 Jun 223,21246742946
31 Mar 223,03245440147
31 Dec 213,00544838646
30 Sep 212,91842237753
30 Jun 212,75439835746
31 Mar 212,58332533743
31 Dec 202,36128532739
30 Sep 202,20027132740
30 Jun 202,11521631239
31 Mar 202,08017431940
31 Dec 192,05114131139
30 Sep 191,9178631048
30 Jun 191,9366730452
31 Mar 191,9488130659
31 Dec 181,91911629165
30 Sep 181,92815625868
30 Jun 181,82018624765
31 Mar 181,71719822054
31 Dec 171,64617520953
30 Sep 171,4936520346
30 Jun 171,3255519341
31 Mar 171,1903517946
31 Dec 161,0353317339
30 Sep 161,0238615232
30 Jun 161,0199714634
31 Mar 161,00111014529
31 Dec 159668314026
30 Sep 159168513829
30 Jun 158856113728

Quality Earnings: MIPH has high quality earnings.

Growing Profit Margin: MIPH's current net profit margins (0.6%) are lower than last year (2.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: MIPH's earnings have declined by 32% per year over the past 5 years.

Accelerating Growth: MIPH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: MIPH had negative earnings growth (-68.6%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (31.5%).

Return on Equity

High ROE: MIPH's Return on Equity (0.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/16 09:03
End of Day Share Price 2026/06/16 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MINAPHARM Pharmaceuticals is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.